Dixie L Esseltine

Author PubWeight™ 35.71^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.	N Engl J Med	2005	15.30
2	Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.	N Engl J Med	2008	13.06
3	Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone.	Haematologica	2006	2.40
4	Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.	J Clin Oncol	2010	2.24
5	Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function.	Cancer	2005	1.50
6	Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.	J Clin Oncol	2009	1.38
7	Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma.	Cancer	2005	1.36